Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice. / Kjellev, Stine; Thim, Lars; Pyke, Charles; Poulsen, Steen Seier.

I: Digestive Diseases and Sciences, Bind 52, Nr. 4, 01.04.2007, s. 1050-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kjellev, S, Thim, L, Pyke, C & Poulsen, SS 2007, 'Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice', Digestive Diseases and Sciences, bind 52, nr. 4, s. 1050-9. https://doi.org/10.1007/s10620-006-9256-4

APA

Kjellev, S., Thim, L., Pyke, C., & Poulsen, S. S. (2007). Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice. Digestive Diseases and Sciences, 52(4), 1050-9. https://doi.org/10.1007/s10620-006-9256-4

Vancouver

Kjellev S, Thim L, Pyke C, Poulsen SS. Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice. Digestive Diseases and Sciences. 2007 apr. 1;52(4):1050-9. https://doi.org/10.1007/s10620-006-9256-4

Author

Kjellev, Stine ; Thim, Lars ; Pyke, Charles ; Poulsen, Steen Seier. / Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice. I: Digestive Diseases and Sciences. 2007 ; Bind 52, Nr. 4. s. 1050-9.

Bibtex

@article{323b984020ec11ddbc23000ea68e967b,
title = "Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice",
abstract = "Trefoil factors (TFFs) are essential for protection and restitution of the gastrointestinal mucosa but many aspects of TFF biology are unclear. Our aim was to compare the localization of endogenous TFFs and binding sites for injected TFF3 in the colon of healthy and colitic mice and to study the effect of TFF3 on dextrane sulfate sodium (DSS)-induced colitis in mice. Expression of endogenous TFF1-3 was examined by in situ hybridization and immunohistochemistry, and the distribution of intravenously, intraperitoneally, and subcutaneously administered (125)I-TFF3 by autoradiography and gamma-counting. The effect of systemically administered TFF3 on DSS-induced colitis was assessed. We found increased expression of endogenous TFF3 and increased binding of injected (125)I-TFF3 in the colon of animals with DSS-induced colitis. The distribution of intraperitoneally and subcutaneously administered (125)I-TFF3 was comparable. Systemic administration of the peptides reduced the severity of colitis. Expression of endogenous TFF3 and binding of systemically administered TFF3 are increased in DSS-induced colitis. Systemic administration of TFF3 attenuates the disease. These findings suggest a role of TFF3 in mucosal protection.",
author = "Stine Kjellev and Lars Thim and Charles Pyke and Poulsen, {Steen Seier}",
year = "2007",
month = apr,
day = "1",
doi = "10.1007/s10620-006-9256-4",
language = "English",
volume = "52",
pages = "1050--9",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice

AU - Kjellev, Stine

AU - Thim, Lars

AU - Pyke, Charles

AU - Poulsen, Steen Seier

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Trefoil factors (TFFs) are essential for protection and restitution of the gastrointestinal mucosa but many aspects of TFF biology are unclear. Our aim was to compare the localization of endogenous TFFs and binding sites for injected TFF3 in the colon of healthy and colitic mice and to study the effect of TFF3 on dextrane sulfate sodium (DSS)-induced colitis in mice. Expression of endogenous TFF1-3 was examined by in situ hybridization and immunohistochemistry, and the distribution of intravenously, intraperitoneally, and subcutaneously administered (125)I-TFF3 by autoradiography and gamma-counting. The effect of systemically administered TFF3 on DSS-induced colitis was assessed. We found increased expression of endogenous TFF3 and increased binding of injected (125)I-TFF3 in the colon of animals with DSS-induced colitis. The distribution of intraperitoneally and subcutaneously administered (125)I-TFF3 was comparable. Systemic administration of the peptides reduced the severity of colitis. Expression of endogenous TFF3 and binding of systemically administered TFF3 are increased in DSS-induced colitis. Systemic administration of TFF3 attenuates the disease. These findings suggest a role of TFF3 in mucosal protection.

AB - Trefoil factors (TFFs) are essential for protection and restitution of the gastrointestinal mucosa but many aspects of TFF biology are unclear. Our aim was to compare the localization of endogenous TFFs and binding sites for injected TFF3 in the colon of healthy and colitic mice and to study the effect of TFF3 on dextrane sulfate sodium (DSS)-induced colitis in mice. Expression of endogenous TFF1-3 was examined by in situ hybridization and immunohistochemistry, and the distribution of intravenously, intraperitoneally, and subcutaneously administered (125)I-TFF3 by autoradiography and gamma-counting. The effect of systemically administered TFF3 on DSS-induced colitis was assessed. We found increased expression of endogenous TFF3 and increased binding of injected (125)I-TFF3 in the colon of animals with DSS-induced colitis. The distribution of intraperitoneally and subcutaneously administered (125)I-TFF3 was comparable. Systemic administration of the peptides reduced the severity of colitis. Expression of endogenous TFF3 and binding of systemically administered TFF3 are increased in DSS-induced colitis. Systemic administration of TFF3 attenuates the disease. These findings suggest a role of TFF3 in mucosal protection.

U2 - 10.1007/s10620-006-9256-4

DO - 10.1007/s10620-006-9256-4

M3 - Journal article

C2 - 17342398

VL - 52

SP - 1050

EP - 1059

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 4

ER -

ID: 4037876